Evidence of Failure of Oral Third-Generation Cephalosporin Treatment for Shigella sonnei Infection
Evidence of Failure of Oral Third-Generation Cephalosporin Treatment for Shigella sonnei Infection
复制标题
DOI：
10.1093/ofid/ofaa113
复制
发表时间：
2020-04-01
影响因子：
4.2
通讯作者：
Watkins, Louise Francois
中科院分区：
文献类型：
--
作者：
Collins, Jennifer P.;Friedman, Cindy R.;Watkins, Louise Francois
2017年，国家卫生部门通知疾病预防控制中心，有4名志贺氏菌病患者在口服第三代头孢菌素治疗后出现顽固性疾病。鉴于志贺氏菌对抗生素的耐药性不断增加，这些病例突出表明有必要评估口服头孢菌素治疗志贺氏菌病的疗效。
In 2017, state health departments notified the Centers for Disease Control and Prevention about 4 patients with shigellosis who experienced persistent illness after treatment with oral third-generation cephalosporins. Given increasing antibiotic resistance among Shigella, these cases highlight the need to evaluate the efficacy of oral cephalosporins for shigellosis.